United Therapeutics (UTHR) Long-Term Investments (2009 - 2026)
United Therapeutics (UTHR) posted Long-Term Investments of $1.3 billion for Q1 2026, down 25.85% sequentially from $1.8 billion in Q4 2025, and down 22.99% YoY from $1.7 billion in Q1 2025.
United Therapeutics (UTHR) Long-Term Investments (2009 - 2026) Analysis & Trends
United Therapeutics has reported Long-Term Investments for 18 years, with the latest figure at $1.3 billion in Q1 2026.
- Quarterly Long-Term Investments fell 22.99% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (down 22.99% YoY) and the FY2025 annual result came in at $1.8 billion, up 20.43% from the prior year.
- Long-Term Investments eased to $1.3 billion in Q1 2026 per UTHR's latest filing, from $1.8 billion in the prior quarter.
- Over five years, Long-Term Investments peaked at $2.1 billion in Q3 2023 and troughed at $1.3 billion in Q3 2024.
- A 5-year average of $1.6 billion and a median of $1.6 billion in 2025 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2023 and 2024: Long-Term Investments surged 45.1% in 2023, then tumbled 37.92% in 2024.
- Over 5 years, Long-Term Investments stood at $1.3 billion in 2022, then soared by 45.1% to $1.9 billion in 2023, then fell by 22.75% to $1.5 billion in 2024, then gained by 20.43% to $1.8 billion in 2025, then retreated by 25.85% to $1.3 billion in 2026.
- According to Business Quant data, Long-Term Investments over the past three periods registered $1.3 billion, $1.8 billion, and $1.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 60.00 Mn |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | 35.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Bn |
| Mar 31, 2026 | 1.32 Bn |
| Dec 31, 2025 | 1.78 Bn |
| Sep 30, 2025 | 1.57 Bn |
| Jun 30, 2025 | 1.92 Bn |
| Mar 31, 2025 | 1.71 Bn |
| Dec 31, 2024 | 1.48 Bn |
| Sep 30, 2024 | 1.28 Bn |
| Jun 30, 2024 | 1.33 Bn |
| Mar 31, 2024 | 1.49 Bn |
| Dec 31, 2023 | 1.91 Bn |
| Sep 30, 2023 | 2.06 Bn |
| Jun 30, 2023 | 2.02 Bn |
| Mar 31, 2023 | 1.77 Bn |
| Dec 31, 2022 | 1.32 Bn |
| Sep 30, 2022 | 1.44 Bn |
| Jun 30, 2022 | 1.64 Bn |
| Mar 31, 2022 | 1.56 Bn |
| Dec 31, 2021 | 1.65 Bn |
| Sep 30, 2021 | 1.51 Bn |